Treatment of problematic infantile hemangiomas with propranolol: a series of 40 cases and review of the literature
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2014, Vol 68, Issue
Abstract
Infantile hemangiomas (IH) are neoplastic proliferations of endothelial cells which occur with an incidence of 10 to 12% within the first year of life. IH grow after birth and usually regress spontaneously, but still can lead to deformities when they are located in the facial areas of the lip, eyelid, nasal tip or the ear. We wanted to share our experience in the treatment of problematic IH with propranolol. A retrospective review of medical charts was performed for 40 consecutive children treated with propranolol because of problematic IH between 2009 and 2012. 40 patients (33 girls, 7 boys) with a median age of 4.2 months (aged 1 to 11 months) were treated because of problematic IH. Rapid improvement was reported in the first days of treatment in 38 patients. In one case we had to terminate the treatment because serious tachycardia developed within the first 48 hours after propranolol was started. In this case the patient benefited from alternative treatment with timolol maleate gel. 35 patients (87%) showed an excellent response with complete resolution of the lesion. 4 patients (10%) showed a good result with >50% reduction in the size of the hemangioma. Also a patient with residual IH after terminating oral propranolol benefited from topical treatment with timolol maleate gel. A minor side effect was poor weight gain during prolonged treatment in one patient and tachycardia in another patient in which case we had to terminate the treatment. Conclusions: Our observations show that gradually increasing the dosage of propranolol up to 3 mg/kg and gradually weaning the dosage is safe and effective in treatment of problematic IH. Timolol maleate gel should be considered as a complementary treatment for residual hemangiomas after terminating propranolol treatment or as an alternative treatment in patients who do not tolerate oral propranolol well.
Authors and Affiliations
Marzanna Oksiuta, Ewa Matuszczak, Wojciech Dębek, Adam Hermanowicz, Marzena Tylicka
Keywords
Related Articles
- EP ID EP67484
- DOI -
- Views 127
- Downloads 0
Modyfikacje epigenetyczne – ważny mechanizm w zaburzeniach cukrzycy
W poszukiwaniu wyjaśnienia patomechanizmów cukrzycy, a zwłaszcza podłoża rozwoju jej powikłań naczyniowych (mikro- i makroangiopatii), mimo bieżącego, dobrego wyrównania cukrzycy, zwrócono uwagę na rolę dziedziczenia poz...
Amylin under examination. Fibrillogenic polypeptide of pancreatic amyloid
In patients or animals affected by 2 type diabetes mellitus (diabetes mellitus type 2, DM2, non-insulin-dependent diabetes mellitus, NIDDM) or pancreatic tumor disease e.g., insulinoma, some pathological deposits, called...
TSG-6 protein and its role during maturation of ovarian follicles
TSG-6 is an ~35 kDa glycoprotein belonging to the hyaluronan binding family. Its expression is induced as a result of an inflammatory condition and during ovulation. TSG-6 is a crucial protein engaged in extracellular m...
The role of centrosomes in cells and their potential contribution to carcinogenesis
The centrosomes are subcellular organelles composed of two centrioles surrounded by a pericentriolar material. In animal cells they are responsible for the organization of the interphase microtubule cytoskeleton includin...
TLR function in autoimmunological processes
TLRs (Toll-like receptors) are found in many different vertebrate and invertebrate species. TLRs have important functions in cell activation of the nonspecific immune response as well as in the indirect specific immune r...